Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hangzhou Tigermed Consulting Co Ltd

3347
Current price
25.95 HKD +0.2 HKD (+0.78%)
Last closed 25.95 HKD
ISIN CNE1000040M1
Sector Healthcare
Industry Diagnostics & Research
Exchange Hong Kong Stock Exchange
Capitalization 42 443 507 815 HKD
Yield for 12 month -40.00 %
1Y
3Y
5Y
10Y
15Y
3347
21.11.2021 - 28.11.2021

Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services. In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China. Address: Shengda Science Park, Hangzhou, China, 310051

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

379.94 HKD

P/E ratio

17.9577

Dividend Yield

2.41 %

Current Year

+8 085 130 108 HKD

Last Year

+7 758 213 544 HKD

Current Quarter

+1 859 263 297 HKD

Last Quarter

+1 817 835 352 HKD

Current Year

+3 118 987 423 HKD

Last Year

+3 049 912 897 HKD

Current Quarter

+771 854 188 HKD

Last Quarter

+687 761 956 HKD

Key Figures 3347

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 690 873 658 HKD
Operating Margin TTM 20.4 %
PE Ratio 17.9577
Return On Assets TTM 3.11 %
PEG Ratio
Return On Equity TTM 5.41 %
Wall Street Target Price 379.94 HKD
Revenue TTM 7 025 487 574 HKD
Book Value 24.08 HKD
Revenue Per Share TTM
Dividend Share 0.57 HKD
Quarterly Revenue Growth YOY -10.9 %
Dividend Yield 2.41 %
Gross Profit TTM 2 806 089 102 HKD
Earnings per share 1.39 HKD
Diluted Eps TTM 1.39 HKD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -68.4 %
Profit Margin 16.06 %

Dividend Analytics 3347

Dividend growth over 5 years

Continuous growth

3 years

Payout Ratio 5 years average

19 %

Dividend History 3347

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.62
Ex Dividend Date 07.06.2024
Forward Annual Dividend Yield 4.61 %
Last Split Factor
Payout Ratio 85.48 %
Last Split Date
Dividend Date

Stock Valuation 3347

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 17.9577
Forward PE 13.4771
Enterprise Value Revenue 5.7222
Price Sales TTM 6.0414
Enterprise Value EBITDA 19.7865
Price Book MRQ 0.9827

Financials 3347

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 3347

For 52 weeks

21.3 HKD 48.68 HKD
50 Day MA 29.54 HKD
Shares Short Prior Month
200 Day MA 30.93 HKD
Short Ratio
Shares Short
Short Percent